Skip to main content
Log in

Der celluläre cytotoxische Test in der Tumorimmunologie

The lymphocyte cytotoxicity test in tumor immunology

  • Übersichten
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

The cytotoxic action of lymphocytes on cancer cells in vitro indicates sensitization of the patient against his own tumor. The technical difficulties of this test and possibilities of standardization and simplifying the procedure are discussed. Critical steps are isolation of lymphocytes and culturing target cells without loosing their specific antigenic structure. The need for specificity controls both for lymphocytes and tumor cells is emphasized.

Labelling tumor cells with isotopes represents a major improvement in evaluating the result. The role of thymus- and bone marrow-dependent lymphocytes as well as blocking factors in the serum of tumor patients can be analyzed in the cytotoxic assay. A better understanding of these mechanisms may facilitate a therapeutic approach by manipulating the interaction of tumor cells and host.

Zusammenfassung

Die cytotoxische Reaktion von Lymphocyten gegen Krebszellen in vitro liefert ein Maß für die Sensibilisierung eines Patienten gegen seinen eigenen Tumor. Die technischen Schwierigkeiten dieses in vitro-Testes und die Möglichkeiten einer weiteren Standardisierung und Vereinfachung werden diskutiert. Kritisch sind insbesondere die Methodik der Lymphocytenisolie-rung und die Züchtung von Target-Zellen unter Erhaltung ihrer Antigenstruktur. Die Spezifität der Reaktion muß durch Kontrollen sowohl bei den Lymphocyten wie bei den Target-Zellen gesichert werden.

Die Markierung der Tumorzellen mit Isotopen erleichtert die Auswertung erbeblich. Die Rolle von thymus- bzw. knochenmarks-abhängigen Lymphocyten sowie blockierender Faktoren im Serum von Tumorpatienten ist durch den Test einer Analyse zugänglich. Erst eine bessere Kenntnis dieser Vorgänge wird therapeutische Versuche ermöglichen, die Beziehung zwischen Tumor und Wirtsorganismus gezielt zu beeinflussen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. Baldwin, R.W., Price, M.R., Robins, R.A.: Significance of serum factors modifying cellular immune responses to growing tumors. Brit. J. Cancer28, Suppl. 1, 37 (1973b)

    PubMed  Google Scholar 

  2. Bean, M.A., Pees, H., Rosen, G., Oettgen, H.F.: Prelabeling target cells with3H-proline as a method for studying lymphocyte cytotoxicity. Nat. Cancer Inst. Monogr.37, 41 (1973)

    PubMed  Google Scholar 

  3. Bean, M.A., Pees, H., Fogh, J.E., Grabstald, H., Oettgen, H.F.: Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a3H-Proline microcytotoxicity test. Int. J. Cancer14, 186 (1974)

    PubMed  Google Scholar 

  4. Bloom, B.: In vitro approaches to the mechanism of cell-mediated immune reactions. Advanc. Immunol.13, 101 (1971)

    Google Scholar 

  5. Böyum, A.: Isolation of mononuclear cells and granulocytes from human blood. Scand. J. clin. Lab. Invest.21, Suppl.97, 77 (1968)

    PubMed  Google Scholar 

  6. Boyle, W.: An extension of the51Cr-release assay for the estimation of mouse cytotoxins. Transplantation6, 761 (1968)

    PubMed  Google Scholar 

  7. Brunner, K.T., Mauel, J., Rudolf, H., Chapuis, B.: Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity. Immunology18, 501 (1970)

    PubMed  Google Scholar 

  8. Brunner, K.T., Cerottini, J.C.: Cytotoxic lymphocytes as effector cells of cell-mediated immunity. Progress in immunology, ed. by B. Amos, p. 385. New York, London: Acad. Press 1971

    Google Scholar 

  9. Bubenik, J., Perlmann, P., Helmstein, K., Moberger, G.: Immune response to urinary bladder tumours in man. Int. J. Cancer5, 39 (1970)

    PubMed  Google Scholar 

  10. Chia, E., Festenstein, H.: Specific cytostatic effect of lymph node cells from normal and T cell-deficient mice on syngenic tumor target cells in vitro and its specific abrogation by body fluids from syngeneic tumor-bearing mice. Europ. J. Immunol.3, 483 (1973)

    Google Scholar 

  11. Cikes, M., Friberg, S.: Expression of H-2 and moloney leukemia virus-determined cell-surface antigens in synchronized cultures of a mouse cell line. Proc. nat. Acad. Sci. (Wash.)68, 566 (1971)

    PubMed  Google Scholar 

  12. Cohen, A.M., Millar, R.C., Ketcham, A.S.: A microassay for cytotoxic antibody using125J-Iododeoxyuridine-labelled target cells. Transplantation13, 57 (1972a)

    PubMed  Google Scholar 

  13. Cohen, A.M., Millar, R.C., Ketcham, A.S.: Host immunity to a growing transplanted methylcholanthren-induced guinea pig sarcoma. Cancer Res.32, 2421 (1972b)

    PubMed  Google Scholar 

  14. Cohen, A.M., Ketcham, A.S., Morton, D.L.: Specific inhibition of sarcoma-specific cellular immunity by sera from patients with growing sarcomas. Int. J. Cancer11, 273 (1973)

    PubMed  Google Scholar 

  15. Coulson, A.S., Chalmers, D.G.: Separation of viable lymphocytes from human blood. Lancet1964 I, 469

    Google Scholar 

  16. Currie, G.A., Basham, C.: Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen. Brit. J. Cancer26, 427 (1972)

    PubMed  Google Scholar 

  17. Currie, G.A.: Effect of active immunization with irradiated tumour cells on specific serum inhibitors of cell-mediated immunity in patients with disseminated cancer. Brit. J. Cancer28, 25 (1973)

    PubMed  Google Scholar 

  18. Della Porta, G., Canevari, S., Fossati, G.: Immune responses to tumour and embryo cells in patients with mammary carcinoma. Brit. J. Cancer28, Suppl.1, 103 (1973)

    PubMed  Google Scholar 

  19. Diehl, V., Jereb, B., Stjernswärd, J., O'Toole, C., Åhström, L.: Cellular immunity to nephroblastoma. Int. J. Cancer7, 277 (1971)

    PubMed  Google Scholar 

  20. Di Saia, P.J., Rutledge, F.N., Smith, J.P., Sinkovics, J.G.: Cell-mediated immune reactions to two gynecologic malignant tumors. Cancer (Philad.)28, 1129 (1971)

    PubMed  Google Scholar 

  21. Evans, R., Alexander, P.: Mechanism of immunologically specific killing of tumour cells by macrophages. Nature (Lond.)236, 168 (1972)

    PubMed  Google Scholar 

  22. Hellström, I., Evans, C.A., Hellström, K.E.: Cellular immunity and its serum-mediated inhibition in Shope-virus-induced rabbit papillomas. Int. J. Cancer4, 601 (1969)

    PubMed  Google Scholar 

  23. Hellström, I., Hellström, K.E., Sjörgen, H.O.: Serum mediated inhibition of cellular immunity to methylcholanthren-induced murine sarcomas. Cell. Immunol.1, 18 (1970a)

    PubMed  Google Scholar 

  24. Hellström, I., Hellström, K.E., Bill, A.H., Pierce, G.E., Yang, J.P.S.: Studies on cellular immunity to human neuroblastoma cells. Int. J. Cancer6, 172 (1970b)

    PubMed  Google Scholar 

  25. Hellström, I., Sjögren, H.O., Warner, G., Hellström, K.E.: Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int. J. Cancer7, 226 (1971a)

    PubMed  Google Scholar 

  26. Hellström, I., Hellström, K.E., Sjögren, H.O., Warner, G.A.: Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity. Int. J. Cancer8, 185 (1971b)

    PubMed  Google Scholar 

  27. Hellström, I., Hellström, K.E.: Colony inhibition and cytotoxicity assays. In: In vitro methods in cell-mediated immunity, ed. by B.R. Bloom, P.R. Glade, p. 409. New York, London: Acad. Press 1971c

    Google Scholar 

  28. Hellström, I., Hellström, K.E., Sjögren, H.O.: Some recent information on „blocking antibodies“ as studied in vitro. Transplant. Proc.3, 1221 (1971d)

    Google Scholar 

  29. Hellström, K.E., Hellström, I.: Persönliche Mitteilung (1973a)

  30. Hellström, I., Warner, G.A., Hellström, K.E., Sjögren, H.O.: Sequential studies on cell-mediated tumor immunity and blokking serum activity in ten patients with malignant melanoma. Int. J. Cancer11, 280 (1973b)

    PubMed  Google Scholar 

  31. Heppner, G.H., Stolbach, L., Byrne, M., Cummings, F.J., McDonough, E., Calabresi, P.: Cell-mediated and serum blokking reactivity to tumor antigens in patients with malignant melanoma. Int. J. Cancer11, 245 (1973)

    PubMed  Google Scholar 

  32. Holm, G., Perlmann, P.: Phytohaemagglutinin-induced cytotoxic action of unsensitized immunologically competent cells on allogeneic and xenogeneic tissue culture cells. Nature (Lond.)207, 818 (1965)

    PubMed  Google Scholar 

  33. Holm, G., Perlmann, P.: Quantitative studies on phytohaemagglutinin-induced cytotoxicity by human lymphocytes against homologous cells in tissue culture. Immunology12, 525 (1967)

    PubMed  Google Scholar 

  34. Jagarlamoody, S.M., Aust, J.C., Tew, R.H., McKhann, C.F.: In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique. Proc. nat. Acad. Sci. (Wash.)68, 1346 (1971)

    PubMed  Google Scholar 

  35. Jimenez, L., Bloom, B.R., Blume, M.R., Oettgen, H.F.: On the number and nature of antigen-sensitive lymphocytes in the blood of delayed-hypersensitive human donors. J. exp. Med.133, 740 (1971)

    PubMed  Google Scholar 

  36. Kersey, J.H., Yunis, E.J., Todaro, G.J., Aaronson, S.A.: HL-A antigens of human tumor-derived cell lines and viral transformed fibroblasts in culture. Proc. Soc. exp. Biol. (N.Y.)143, 453 (1973)

    Google Scholar 

  37. Kumar, S., Taylor, G.: Specific lymphocytotoxciity and blokking factors in tumors of the central nervous system. Brit. J. Cancer28, Suppl.1, 135 (1973)

    PubMed  Google Scholar 

  38. Lamon, E.W., Wigzell, H., Klein, E., Andersson, B., Skurzak, H.M.: The lymphocyte response to primary Moloney sarcoma virus tumours in BALB/c mice. J. exp. Med.137, 1472 (1973)

    PubMed  Google Scholar 

  39. Leneva, V., Svet-Moldavsky, G.J.: Susceptibility of tumor cells in different phases of the mitotic cycle to the effect of immune lymphocytes. J. nat. Cancer Inst.52, 699 (1974)

    PubMed  Google Scholar 

  40. Lengerova, A.: The expression of normal histocompatibility antigens in tumor cells. Advanc. Cancer Res.16, 235 (1972)

    Google Scholar 

  41. Levy, N.L., Mahaley, M.S., Day, E.D.: In vitro demonstration of cell-mediated immunity to human brain tumors. Cancer Res.32, 477 (1972)

    PubMed  Google Scholar 

  42. MacPherson, B.R., Pilch, Y.H.: Cellular cytolysis in vitro: mechanisms underlying a quantitative assay for cellular immunity. J. nat. Cancer Inst.48, 1619 (1972)

    PubMed  Google Scholar 

  43. Ménard, S., Pierotti, M., Colnaghi, M.I.: A51Cr microtest for cellular immunity. Transplantation14, 155 (1972)

    PubMed  Google Scholar 

  44. Oettgen, H.F., Bean, M.A., Klein, G.: Workshop in human tumor immunology. Cancer Res.32, 2845 (1972)

    PubMed  Google Scholar 

  45. O'Toole, C., Perlmann, P., Unsgaard, B., Moberger, G., Edsmyr, F.: Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy. Int. J. Cancer10, 77 (1972)

    PubMed  Google Scholar 

  46. O'Toole, C., Perlmann, P., Unsgaard, B., Almgård, L.E., Johansson, B., Moberger, G., Edsmyr, F.: Cellular Immunity to human urinary bladder carcinoma. II. Effect of surgery and preoperative irradiation. Int. J. Cancer10, 92 (1972)

    PubMed  Google Scholar 

  47. O'Toole, C., Perlmann, P., Wigzell, H., Unsgaard, B., Zetterlund, C.G.: Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells? Lancet1973 I, 1085

    Google Scholar 

  48. Pees, H.: Probleme des cellulären cytotoxischen Testes bei menschlichen Tumoren. Verh. dtsch. Ges. inn. Med.80, 1974 (im Druck)

  49. Pees, H., Bean, M.A.: Unveröffentlichte Ergebnisse (1972)

  50. Perlmann, P., Broberger, O.: In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells. J. exp. Med.117, 717 (1963)

    PubMed  Google Scholar 

  51. Perlmann, P., Holm, G.: Cytotoxic effects of lymphoid cells in vitro. Advanc. Immunol.11, 117 (1969)

    Google Scholar 

  52. Perlmann, P., O'Toole, C., Unsgaard, B.: Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma. Nat. Cancer Inst. Monogr.35, 223 (1972a)

    PubMed  Google Scholar 

  53. Perlmann, P., Perlmann, H., Wigzell, H.: Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. Transplant. Rev.13, 91 (1972b)

    PubMed  Google Scholar 

  54. Sinkovics, J.G.: Nat. Cancer Inst. Monogr.37, 127 (1973)

    Google Scholar 

  55. Sjögren, H.O., Hellström, I., Bansal, S.C., Hellström, K.E.: Suggestive evidence that the „blocking antibodies“ of tumor-bearing individuals may be antigen-antibody complexes. Proc. nat. Acad. Sci. (Wash.)68, 1372 (1971)

    PubMed  Google Scholar 

  56. Sjögren, H.O., Hellström, I., Bansal, S.C., Warner, G.A., Hellström, K.E.: Elution of „blocking factors“ from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes. Int. J. Cancer9, 274 (1972)

    PubMed  Google Scholar 

  57. Steele, W.R., Hensen, S.A., Vincent, M.M., Fuccillo, D.A., Bellanti, J.A.: A51Cr microassay technique for cell-mediated immunity to viruses. J. Immunol.110, 1502 (1973)

    PubMed  Google Scholar 

  58. Takasugi, M., Klein, E.: A microassay for cell-mediated immunity. Transplantation9, 219 (1970)

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Mit Unterstützung der Deutschen Forschungsgemeinschaft Pe 163/1–4.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pees, H.W. Der celluläre cytotoxische Test in der Tumorimmunologie. Klin Wochenschr 53, 1–6 (1975). https://doi.org/10.1007/BF01466850

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01466850

Key words

Schlüsselwörter

Navigation